Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events what do patients parkinson’s disease value most episode treatments
… How Do We Get Drug Labeling Based on Patient Reported Outcomes? … of labeling, the important thing to realize is that - what is it that we want to say? What is it that you want to … proposition in simple language that can be understood by patients or other stakeholders as well. There is no point of …
… can make or break the adoption of your innovation. What to Do: Engage with payers early in the development process. … development on these aspects, you can enhance your product’s appeal. 2. Map Prescribing Pathways for Current Treatment …
… data to inform decision-making is critical to your product’s development and success. But sometimes, unanticipated … questions arise, and you need information quickly. What do you do if the data you need is unavailable or not easily …
… More than ever, health economic information affects how patients, providers, payers , and regulators make decisions, … exchange of information pertaining to your product’s value proposition. Typical studies include: Study Type Description Burden of Illness Disease incidence and prevalence; real-world outcomes; costs …
… the continually evolving body of evidence in a particular disease or treatment area. High-quality literature reviews … Identify clinical and cost effectiveness of comparator treatments Formulate best practices in economic modeling … Literature Review Reasons for Conducting To collect the most recent, robust data and viewpoints on a disease and its …
… that will seek perspectives of those affected by Alzheimer’s Share on: May 22, 2018 Understanding What Matters Most to Alzheimer's patients and their caregivers to help inform the drug …
… RTI Named One of the World’s Most Ethical Companies for the Fifth Year Share on: March … governance, diversity, and initiatives to support a strong value chain. The process serves as an operating framework to …
… scientific evidence that demonstrates your product’s safety, efficacy, and value, but also on effectively … and improve shared healthcare decision making. From patients and caregivers to busy medical professionals and … shared decision-making in clinical practice. What to consider when translating your research into plain …
… Your Pharma or Medical Technology Product Development The value of your data may be greater than you think. Unexplored … outcomes with clinician-reported outcomes. It's possible to examine if and why treatment responses vary over time and across disease subtypes. Or you can determine if your missing data …
… 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a … where you’ll learn: Health Technology Assessment: How do HTA bodies define rare or ultra-orphan diseases? How do HTA bodies appraise rare disease drugs? What are the key challenges to developing cost-effectiveness …